UBS Group
ASXC

UBS Group’s Asensus Surgical, Inc. ASXC Stock Holding History

UBS Group’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-265,000
Closed -$119K – 11309
2022
Q3 		$119K Hold
265,000
– – ﹤0.01% 5559
2022
Q2 		$105K Buy
+265,000
New +$118K ﹤0.01% 5399

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's ASXC Position: Q3 2024 in Review

UBS Group sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 283,536 shares — an estimated $94.4K sold.

UBS Group first reported a position in ASXC in Q4 2014 and held it in 37 quarters. The position peaked at $3.37M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • UBS Group reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 283,536 Asensus Surgical, Inc. shares in Q3 2024, an estimated $94.4K.
  • UBS Group first reported a position in Asensus Surgical, Inc. in Q4 2014 and held it in 37 quarters.
  • UBS Group's Asensus Surgical, Inc. position peaked at $3.37M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.